| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/24/2008 | WO2008087034A2 Cyclodextrin formulations |
| 07/24/2008 | WO2008086953A1 Colloidal solution |
| 07/24/2008 | WO2008086844A2 Co-precipitate, method for preparing the same and uses thereof |
| 07/24/2008 | WO2008086804A2 Use of i) a polyglycol and n) an active drug substance for the preparation of a pharmaceutical composition for i) mitigating the risk of alcohol induced dose dumping and/or ii) reducing the risk of drug abuse |
| 07/24/2008 | WO2008086742A1 A medicament for improving the ovum quality and treating female infertility |
| 07/24/2008 | WO2008086733A1 New pharmaceutical composition |
| 07/24/2008 | WO2008086698A1 A forsythoside injection and preparation thereof |
| 07/24/2008 | WO2008068418A3 Textile and/or fiber processing method using an active ingredient composed of nanoparticles<0} |
| 07/24/2008 | WO2008068417A3 Control and/or monitoring method for the salting-out of at leat one active ingredient impregnated in a textile<0} |
| 07/24/2008 | WO2008060934A8 Formulations of tetrahydropyridine antiplatelet agents for parenteral or oral administration |
| 07/24/2008 | WO2008060359A3 Biodegradable ocular implants and methods for treating ocular conditions |
| 07/24/2008 | WO2008058233A3 In vivo bioreactors and methods of making and using same |
| 07/24/2008 | WO2008057267A3 Co-processed microcrystalline cellulose and sugar alcohol as an excipient for tablet formulations |
| 07/24/2008 | WO2008057203A3 A work holder for use in and a method for making a lollipop |
| 07/24/2008 | WO2008053250A3 Formulations for delivery via pressurised metered dose inhalers comprising an essential oil as suspension stabiliser |
| 07/24/2008 | WO2008048387A3 Stimulus-release carrier, methods of manufacture and methods of treatment |
| 07/24/2008 | WO2008043825A3 Pharmaceutical anti-infective composition for inhalation. |
| 07/24/2008 | WO2008030469A3 Soft chewable, tablet, and long-acting injectable veterinary antibiotic formulations |
| 07/24/2008 | WO2008022932A3 Controlled release system and method for manufacturing the same |
| 07/24/2008 | WO2008021451A3 Human-powered dry powder inhaler and dry powder inhaler compositions |
| 07/24/2008 | WO2008020286A3 Pharmaceutical compositions of duloxetine |
| 07/24/2008 | WO2008020269A3 A method of treating tumors with azaxanthones |
| 07/24/2008 | WO2008014456A3 Combination therapy for otitis with antiseptic and ph adjustment |
| 07/24/2008 | WO2008013710A3 Chewable tablet containing phenylephrine |
| 07/24/2008 | WO2007143163A3 Pharmaceutical compositions for sustained release of phenyephrine |
| 07/24/2008 | WO2007127799A3 Polymer submicron particle preparation by surfactant- mediated precipitation |
| 07/24/2008 | WO2007117536A3 Calcium phosphate complex in acid containing chewing gum |
| 07/24/2008 | WO2007108010B1 Taste masked pharmaceutical composition for oral solid dosage form and process for preparing the same using magnesium aluminium silicate |
| 07/24/2008 | WO2007100745A3 Apparatus and formulations for suprachoroidal drug delivery |
| 07/24/2008 | WO2007053533A8 Sodium chloride solution for drug reconstitution or dilution |
| 07/24/2008 | WO2006116107A3 Immunoliposome composition for targeting to a her2 cell receptor |
| 07/24/2008 | US20080177254 Method and Apparatus for Automatically Modifying Delivery Profile of Drug Delivery System |
| 07/24/2008 | US20080177213 Hydrogels of hydrophilic polyurethanes (meth)acrylates |
| 07/24/2008 | US20080177153 Therapeutic agent delivery systems and devices |
| 07/24/2008 | US20080177083 Trichomonas vaginalis infections and cecal amoeba infections; oral , intravenous and vaginal preparations; antiprotozoa agents; side effect reduction, nontoxic; superior to dextro-ornidazole and racemic ornidazole |
| 07/24/2008 | US20080177075 Use of zinc ion chelate compound such as 8-hydroxyquinoline for intra-vaginal administration to control of egg fertilization by sperm and for progeny sex determination and/or for reducing incidence of defective progeny; |
| 07/24/2008 | US20080177064 Dipeptidyl peptidase inhibitors |
| 07/24/2008 | US20080177053 DNA nanocage by self-organization of DNA and process for producing the same, and DNA nanotube and molecule carrier using the same |
| 07/24/2008 | US20080176960 Biodegradable biopolymers, method for their preparation and functional materials constituted by these biopolymers |
| 07/24/2008 | US20080176959 Biodegradable polyphosphates complex for controlled release of bioactive substances and related methods |
| 07/24/2008 | US20080176800 Methods for the delivery of bioactive substances with biodegradable polyphosphates |
| 07/24/2008 | US20080176791 a mixture of antihemophilic factor, bulking agent selected from mannitol, glycine and alanine, stabilizer agents selected from sucrose, trehalose, raffinose and arginine, calcium chloride, sodium chloride and buffers, having storage stability |
| 07/24/2008 | US20080175921 Once daily, low viscosity; very fine needle injectable suspension; pharmacokinetic performance |
| 07/24/2008 | US20080175920 Polymer Capsule and Process For the Preparation Thereof |
| 07/24/2008 | US20080175919 Urea Compositions With Cooling Effect |
| 07/24/2008 | US20080175918 Chemically cross-linked elastomeric microcapsules |
| 07/24/2008 | US20080175917 Microparticles containing a H+,K+-ATP-ase inhibitor |
| 07/24/2008 | US20080175916 Advancing distal portion of catheter to existing blood vessel and releasing medicant |
| 07/24/2008 | US20080175915 Forming controlled release, core shell drug delivery materials; accelerating second liquid stream to surround first stream and acoustic wave vibrating |
| 07/24/2008 | US20080175914 Inflammatory and/or allergic diseases; cognitive impairment |
| 07/24/2008 | US20080175912 Stabilized, entrapped aqueous dispersions; delivery of personal, household and medical care active agents; easy handling |
| 07/24/2008 | US20080175911 Compositions and methods for soft tissue repair |
| 07/24/2008 | US20080175910 Pharmaceutical dosage forms for controlled release producing at least a timed pulse |
| 07/24/2008 | US20080175909 Delivery device containing venlafaxine and memantine and method of use thereof |
| 07/24/2008 | US20080175908 Tablet-in-tablet compositions |
| 07/24/2008 | US20080175907 Oral insulin therapies and protocol |
| 07/24/2008 | US20080175906 Levonorgestrel, ionic disintegrant and hydrophilic water insoluble nonionic excipient; emergency contraception; easy, accurate administration |
| 07/24/2008 | US20080175905 Estrogen/serm and estrogen/progestin bi-layer tablets |
| 07/24/2008 | US20080175904 Compressed chewable supplement dosage form; formulated without wet granulation step |
| 07/24/2008 | US20080175903 Subsedative dosage form of zopiclone optical isomer; instantaneous and sustained release |
| 07/24/2008 | US20080175902 Methods for slowing the progression of multiple sclerosis |
| 07/24/2008 | US20080175901 Reduced polymorphic conversion; estrogen receptor modulator pharmacokinetics |
| 07/24/2008 | US20080175900 Pharmaceutical formulations of an anhydrate crystal form of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol |
| 07/24/2008 | US20080175899 Formulation for promoting sinus health in nasal cavities |
| 07/24/2008 | US20080175898 Oral drug capsule component incorporating a communication device |
| 07/24/2008 | US20080175897 Dosage forms for administering combinations of drugs |
| 07/24/2008 | US20080175896 high affinity to a fibroblast growth factor-inducible 14 (Fn14) cell surface receptor; induce cell death; drug target at diseased cell of cancer, atherosclerosis, stroke, lupus, nephritis, multiple sclerosis, rheumatoid arthritis, degenerative or inflammation; reduce side effect |
| 07/24/2008 | US20080175895 System, devices, and methods for iontophoretic delivery of compositions including antioxidants encapsulated in liposomes |
| 07/24/2008 | US20080175894 Methods of treating neurological conditions with hematopeitic growth factors |
| 07/24/2008 | US20080175893 drug deliverying nitric oxide containing liposomes for hyperplasia, atherosclerosis; drug conjugated with antibody for drug target at specific cells; delivery rosiglitazone; reduce side effect; freezing under pressure |
| 07/24/2008 | US20080175892 fullerene carbon nanotube linking to paclitaxel through polyethylene glycol, serinol, succinimidyl-3-(2-pyridyldithio)-propionate or succinic acid; anticarcinogenic agents treating lung cancer; drug target with antibody; aerosols drug delivery |
| 07/24/2008 | US20080175891 transdermal patches for drug delivery AICA riboside, a prodrugs, or antiischemic agent; provides heat, modulation of blood flow; pre- or after-treatment of surgery; including anticoagulants, allopurinol; drug delivery device for sustained release |
| 07/24/2008 | US20080175890 Transdermal delivery systems |
| 07/24/2008 | US20080175889 Method and composition for coating wounds and protecting skin using a polyether polyurethane solution |
| 07/24/2008 | US20080175888 regulate an immune response in a mammal contains kiwi fruit plant extract; veterinary medicine; antiinflammatory agent for treating allergic and non-allergic inflammatory conditions, skin disorders; side effect reduction |
| 07/24/2008 | US20080175887 Treatment of Asthma and Chronic Obstructive Pulmonary Disease With Anti-proliferate and Anti-inflammatory Drugs |
| 07/24/2008 | US20080175884 Polymer coatings as carriers for the drug delivery of a methosyaminocarbonyloxy derivative of rapamycin and another drug(s) such as an antiproliferative agent, anticoagulant, etc.; reduces restenosis in vasculature procedures to a level of 0-25%; coronary/periferal stents; grafts ; balloons |
| 07/24/2008 | US20080175878 Protease for activating clotting factor VII |
| 07/24/2008 | US20080175876 Novel Chitinase and Uses Thereof |
| 07/24/2008 | US20080175873 cores comprising 1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexanol, gelling agents and excipients, having sustained release coatings; higher bioavailability and side effect reduction |
| 07/24/2008 | US20080175872 Controlled Release Dosage Form Containing Lercanidipine and a Performance-enhancing Acid |
| 07/24/2008 | US20080175797 Preventing airway mucus production by administration of egf-r antagonists |
| 07/24/2008 | US20080175796 Delivery of Drug Esters Through an Inhalation Route |
| 07/24/2008 | US20080175795 e.g. 3-{4-[4-(2-amino-2-carbamoyl-ethyl)-phenoxy]-phenyl)-propionic acid; antiinflammatory and immunological diseases, cytokines (TNF- alpha , IL-1, IL-6), orexin, nitric oxide synthase inhibitor; obesity, hyperlipidemia, migraine, asthma, chronic obstructive pulmonary disease, osteoarthritis |
| 07/24/2008 | US20080175794 Substituted Pyridazinyl- and Pyrimidinyl-Quinolin-4-Ylamine Analogues |
| 07/24/2008 | US20080175793 Propellants; aerosols; skin disorders |
| 07/24/2008 | DE112006001898T5 Vorrichtung zur Inhalation von Arzneimitteln Device for inhalation of drugs |
| 07/24/2008 | DE102007004424A1 Eisenoxid-bindende Peptide Iron oxide-binding peptides |
| 07/24/2008 | CA2676010A1 Methods and compositions for the delivery of a therapeutic agent |
| 07/24/2008 | CA2675760A1 Treatment of pain with naloxone |
| 07/24/2008 | CA2675356A1 High dose film compositions and methods of preparation |
| 07/24/2008 | CA2675190A1 Cyclodextrin formulations |
| 07/24/2008 | CA2674422A1 Composition and method of stabilized sensitive ingredient |
| 07/24/2008 | CA2674420A1 Composition and method of stabilized sensitive ingredient |
| 07/24/2008 | CA2674418A1 Composition and method of stabilized sensitive ingredient |
| 07/24/2008 | CA2672425A1 Galenic form for the transmucosal delivery of paracetamol |
| 07/24/2008 | CA2661348A1 Anionic latex as a carrier for bioactive ingredients and methods for making and using the same |
| 07/24/2008 | CA2659858A1 Liposome treatment of viral infections |
| 07/23/2008 | EP1947182A1 Fibroblast growth factor-23 molecules and uses thereof |
| 07/23/2008 | EP1947137A1 Biodegradable particle and method for producing the same |